1.3 USD
-0.02 (-1.52%)
1.3 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to OPK. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 3.74. This target is 187.95% above the current price.
- OPK was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about OPK.
- In the previous month the buy percentage consensus was at a similar level.
- OPK was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-20 | JP Morgan | Initiate | Neutral |
| 2025-10-31 | Jefferies | Downgrade | Buy -> Hold |
| 2025-10-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-25 | JP Morgan | Initiate | Neutral |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-29 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
OPKO HEALTH INC / OPK FAQ
Can you provide the average price target for OPKO HEALTH INC stock?
11 analysts have analysed OPK and the average price target is 3.74 USD. This implies a price increase of 187.95% is expected in the next year compared to the current price of 1.3.
What is the consensus rating for OPKO HEALTH INC (OPK) stock?
The consensus rating for OPKO HEALTH INC (OPK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for OPKO HEALTH INC stock?
The number of analysts covering OPKO HEALTH INC (OPK) is 11.